News Focus
News Focus
icon url

volgoat

06/16/16 6:56 AM

#266829 RE: Protector #266827

Lol, try a .40c stock, more dilution, kicked off of R3K and a RS coming, yes it is all good, except the data and the pps and Bavi.

Other than that, keep buying........good idea.....or not.....yeah, probably not.....
icon url

Carboat

06/17/16 4:07 AM

#266867 RE: Protector #266827

With drugs like Bavituximab in the mix the side effects can be milded and it brings non of its own. The number of responders increases and with the immune activation one can eliminate the risk of getting the same disease again.

All conjecture not proven in any late stage trial.